NCT02295059 2026-04-03
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
City of Hope Medical Center
Phase NA Active not recruiting
Clinical Trials
43 trialsNCT01881048 2026-01-29
Window of Opportunity Study Targeting the Inflammatory Milieu
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT01351805 2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA Completed
NCT06055894 2025-11-13
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT00244816 2025-10-23
Taxoprexin® Treatment for Advanced Eye Melanoma
American Regent, Inc.
Phase 2 Completed
NCT00422877 2025-10-16
Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract
American Regent, Inc.
Phase 2 Terminated
NCT00249262 2025-09-26
Taxoprexin Treatment for Advanced Skin Melanoma
American Regent, Inc.
Phase 2 Completed
NCT07136519 2025-08-22
Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma
Affiliated Hospital of Guangdong Medical University
Phase 2 Not yet recruiting
NCT00243867 2025-08-01
Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer
American Regent, Inc.
Phase 3 Completed
NCT07036952 2025-07-24
Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase NA Enrolling by invitation
NCT00087776 2025-07-23
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma
American Regent, Inc.
Phase 3 Terminated
NCT03831178 2025-06-26
DHA-WIN
AHS Cancer Control Alberta
Phase 2 Active not recruiting
NCT06015971 2025-05-06
Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer
Maimónides Biomedical Research Institute of Córdoba
Phase NA Recruiting
NCT06928701 2025-04-15
NEOMET
University of Eastern Piedmont
Phase NA Recruiting
NCT06918080 2025-04-09
Hepatoprotective Measures for Children at High Risk of NAFLD
Ain Shams University
Phase 4 Active not recruiting
NCT02521753 2025-04-01
OMgObPCOS
Coordinación de Investigación en Salud, Mexico
Phase NA Terminated
NCT04116203 2025-02-28
PCOS
University of Alberta
Phase 1 Completed
NCT03806426 2024-04-25
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
S.L.A. Pharma AG
Phase 3 Active not recruiting
NCT06339372 2024-04-02
Perioperative Supplementation With Immunonutrition and Its Impact on Surgical Outcome and Pain in Oral Cavity or Mandibular Tumours
Cairo University
Phase NA Completed
NCT05116878 2023-09-08
EFFORTS
Mayo Clinic
Phase NA Terminated
NCT02538484 2023-07-17
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT02831582 2023-02-27
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT03598413 2022-09-28
PROTEIN
Royal Surrey County Hospital NHS Foundation Trust
Phase NA Completed
NCT02278965 2022-08-17
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Columbia University
Phase 1 Completed
NCT02101970 2022-01-24
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
University of Kansas Medical Center
Phase NA Completed
NCT02517502 2022-01-24
Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT01733147 2022-01-11
Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids
Mayo Clinic
Phase 4 Completed
NCT01849250 2021-12-28
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
National Cancer Institute (NCI)
Phase 2 Completed
NCT03093207 2020-11-17
Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis
Universidade Estadual Paulista Júlio de Mesquita Filho
Phase 2/3 Completed
NCT03290417 2020-02-18
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT03936621 2019-05-07
Omega
British Columbia Cancer Agency
Phase 2 Unknown
NCT02529332 2018-08-21
Omega-3 Supplementation for Smell Dysfunction
Stanford University
Phase NA Completed
NCT02352779 2017-08-08
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
University of Rochester
Phase NA Completed
NCT02779868 2017-07-25
Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy
Brazilian National Cancer Institute
Phase NA Completed
NCT03147586 2017-05-10
Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy
Mansoura University
Phase 4 Unknown
NCT00253643 2017-04-18
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT00815685 2017-03-23
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT01051154 2016-08-22
DHA-ALL
Coordinación de Investigación en Salud, Mexico
Phase 2 Completed
NCT01032343 2013-08-22
An Immunonutritional Approach to the Prevention of Skin Cancer
University of Manchester
Phase NA Completed
NCT01910948 2013-07-30
PAOPUFAGC
The First Hospital of Jilin University
Phase 4 Unknown
NCT01070355 2011-10-21
EMT
University of Leeds
Phase 2 Completed
NCT00455416 2008-05-21
KLYMF
Oslo University Hospital
Phase 2 Unknown
NCT00146211 2007-12-27
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Amarin Neuroscience Ltd
Phase 3 Completed